CAR-T细胞治疗后非典型髓系肉瘤的FDG PET/CT表现
一例23岁Ph样B细胞急性淋巴细胞白血病(B-ALL)伴JAK2重排男性,多次复发后接受自体UCD-19 CAR-T细胞治疗,治疗后1.5个月出现全身皮肤病变。活检示新发髓系肉瘤(MS),而B-ALL持续缓解。18F-FDG PET/CT显示皮肤、皮下组织、肌肉、骨结构、黏膜、胸膜、纵隔、腹膜、腹膜后及睾丸多发高代谢软组织病变。
要点
- CAR-T治疗后1.5个月出现新发髓系肉瘤,B-ALL仍持续缓解。
- 18F-FDG PET/CT显示皮肤、肌肉、骨、胸膜、腹膜后及睾丸等多部位高代谢软组织病变。
- 髓系肉瘤可表现为CAR-T治疗后非典型全身多发软组织病变。
核心结论
- 本例在自体UCD-19 CAR-T细胞治疗完成后1.5个月出现新发髓系肉瘤,同时B-ALL持续缓解。
研究设计与样本
- 病例报告:一例23岁Ph样B-ALL伴JAK2重排男性,多次复发后接受自体UCD-19 CAR-T细胞治疗。
主要发现
- 患者表现为1周内出现的无数皮肤病变,活检示新发髓系肉瘤,B-ALL持续缓解。
- 18F-FDG PET/CT显示皮肤、皮下组织、肌肉、骨结构、黏膜、胸膜、纵隔、腹膜、腹膜后及睾丸多发明显高代谢软组织病变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 23-year-old man with a history of Ph-Like B-cell acute lymphoblastic leukemia (B-ALL) with JAK2 rearrangement presented with innumerable skin lesions developing over 1 week. Before presentation, he had multiple relapses of his B-ALL and underwent autologous UCD-19 chimeric antigen receptor (CAR) T-cell therapy. Lesions appeared 1.5 months after completion of therapy. Biopsies showed new onset myeloid sarcoma (MS), with continued remission of B-ALL. 18 F-FDG PET/CT showed numerous markedly hypermetabolic soft tissue lesions located in the skin and subcutaneous tissues, muscles, osseous structures, mucosa, pleura, mediastinum, peritoneum, retroperitoneum, and testes.
引用
- Gray DL, Fair J. FDG PET/CT of Atypical Myeloid Sarcoma After CAR T-Cell Therapy. Clin Nucl Med. 2025. PMID: 39988793. doi:10.1097/RLU.0000000000005759
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。